These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 25986611)

  • 1. Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?
    Buday B; Pach PF; Literati-Nagy B; Vitai M; Kovacs G; Vecsei Z; Koranyi L; Lengyel C
    Cardiovasc Diabetol; 2015 May; 14():55. PubMed ID: 25986611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.
    Pei D; Hsia TL; Chao TT; Lin JD; Hsu CH; Wu CZ; Hsieh CH; Liang YJ; Chen YL
    Saudi J Gastroenterol; 2015; 21(3):158-64. PubMed ID: 26021775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
    Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
    Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
    Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T
    PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased liver markers are associated with higher risk of type 2 diabetes.
    Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
    World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
    Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
    Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
    Ciba I; Widhalm K
    Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
    Vozarova B; Stefan N; Lindsay RS; Saremi A; Pratley RE; Bogardus C; Tataranni PA
    Diabetes; 2002 Jun; 51(6):1889-95. PubMed ID: 12031978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease].
    Liu M; Yan HM; Gao X; Gao J
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):253-5. PubMed ID: 17425870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.
    Iacobellis G; Moschetta A; Buzzetti R; Ribaudo MC; Baroni MG; Leonetti F
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):442-7. PubMed ID: 17134955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.
    Ghamar-Chehreh ME; Amini M; Khedmat H; Moayed Alavian S; Daraei F; Mohtashami R; Hadi R; Beyram BA; Taheri S
    Asian Pac J Trop Biomed; 2012 Sep; 2(9):702-6. PubMed ID: 23569998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.
    Zhang Y; Lu X; Hong J; Chao M; Gu W; Wang W; Ning G
    Endocrine; 2010 Oct; 38(2):181-7. PubMed ID: 20972737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans.
    Ter Horst KW; Gilijamse PW; Ackermans MT; Soeters MR; Nieuwdorp M; Romijn JA; Serlie MJ
    Metabolism; 2016 May; 65(5):757-763. PubMed ID: 27085782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.